Cronos Group Posts Revenues Of $12.6 Million, Net Loss Of $161.6 Million

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning reported its first quarter financial results, leaving investors yet again asking why this company has over a three billion dollar valuation. The company recorded revenues of $12.6 million, along with a net loss of $161.6 million.

Revenues were down 26% on a quarter over quarter basis, falling from $17.4 million in the fourth quarter to $12.6 million in the first quarter of 2021. The company also continued to demonstrate an inability to generate a gross profit, instead posting a gross loss of $2.9 million for the period – an improvement over the gross loss of $6.5 million posted a year ago.

Operating expenses meanwhile amounted to $40.5 million, with the company seeing $21.9 million in general and administrative expenses, or about $1.73 for every dollar of net revenue it earned. Sales and marketing meanwhile amounted to $10.3 million, followed by R&D expenditures of $5.1 million.

Other income provided a negative impact of $118.1 million, a result of a loss on derivative liabilities of $116.9 million, as well as $1.7 million in impairments on PPE by the company, offset marginally by interest income of $2.3 million.

Looking to the balance sheet, the company has continued to burn cash, with its cash and cash equivalents falling from $1.1 billion to $1.0 billion over the course of the quarter, a function of negative operating cash flows of $46.0 million, as well as finance cash flows of -$9.3 million and investing cash flows of -$9.7 million. Total current assets declined from $1.4 billion to $1.3 billion as the company continues to burn cash at an impressive rate.

Total current liabilities meanwhile climbed from $206.8 million to $302.6 million, a function of derivative liabilities climbing from $163.4 million to $272.3 million.

Cronos Group last traded at $9.26 on the TSX.


Information for this briefing was found via Sedar, Sedi and Cronos Group. The author has no securities or affiliations related to these organizations. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The $30,000 Gold Case Just Got Stronger | Simon Marcotte

Why Silver’s Move Is ‘Scary’ to Some Miners | Frank Basa

Are Commodities Entering a Generational Cycle? | Terry Lynch

Recommended

First Phosphate Finalizes $16.7 Million Non-Repayable Funding From Government Of Canada

Ottawa Backs First Phosphate Battery Grade Validation Push With $16.7M Boost

Related News

Cronos Group To Close Canadian Facility, Reports Q4 Net Loss Of $133.9 Million

Cronos Group (TSX: CRON) appears to be finally taking steps to address its absolute lack...

Tuesday, March 1, 2022, 08:48:47 AM

Heritage Cannabis Director Resigns Just Ahead Of Year End

When we last checked in with our favorite Canadian extraction play Heritage Cannabis (CSE:CANN) in...

Tuesday, February 11, 2020, 08:45:11 AM

Ginkgo Bioworks To Go Public Via SPAC Route With Soaring Eagle Acquisition Corp

It appears that Cronos Group (TSX: CRON) (NASDAQ: CRON) might be losing its star player....

Tuesday, May 11, 2021, 10:30:00 AM

SEC Charges Cronos Group With Accounting Fraud

Canadian cannabis company Cronos Group Inc (TSX: CRON) and its former senior executive were charged...

Monday, October 24, 2022, 05:52:17 PM

Cronos Group Delays Q3 2021 Results Again, Now Due To Be Filed By February 18

Cronos Group (TSX: CRON) (NASDAQ: CRON) by all accounts appears unable to get a firm...

Sunday, January 30, 2022, 02:37:09 PM